(Q39112759)

English

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade

scientific article published on June 15, 1976

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

P. Collste

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

K. Haglund

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

M. Frisk-Holmberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

M. D. Rawlins

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292

7 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9292

7 October 2022

publication date

1 June 1976

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

15 June 1976

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9292

7 October 2022

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

85-88

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00609464

0 references

Identification of the major urinary metabolite of alprenolol in man, dog and rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of propranolol plasma level to beta-blockade during oral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma propranolol levels in adults With observations in four children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state plasma concentrations of alprenolol in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potency and Time-Effect Relationship in Man of Propranolol 1 and H 56/28 2-Comparative Studies after Oral Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenously Administered Isoproterenol Sulfate Dose-Response Curves in Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The disposition of propranolol. I. Elimination during oral absorption in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind three-dose trial of oral alprenolol in angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alprenolol in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gas chromatographic determination of the secondary amine alprenolol, as its trifluoroacetyl derivative, at nanogram levels in biological fluids

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of alprenolol in acute cardiac arrhythmias.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption of alprenolol in man from tablets with different rates of release

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00609464

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39112759&oldid=2144448773"